Bill > HB222

This bill establishes limits on cost-sharing for insulin. It requires individual disability insurance policies and certificates that cover prescription drugs to limit the insured's copayment or other cost-sharing requirement for insulin to $35 for each 30-day supply, regardless of the amount or type of insulin prescribed. The bill also specifies that insulin coverage is not subject to a deductible, though cost-sharing amounts paid by the insured for insulin must be counted toward the insured's deductible. The provisions of this bill are intended to be codified as part of Montana's existing laws regulating insurance coverage for diabetes treatment and supplies, and the bill takes effect on January 1, 2022.

Health and Social Services

https://laws.leg.mt.gov/legprd/LAW0210W$BSIV.ActionQuery?P_BILL_NO1=222&P_BLTP_BILL_TYP_CD=HB&Z_ACTION=Find&P_SESS=20211